1. Cancer statistics, 2024
2. Research progress on second-line treatment for hepatocellular carcinoma after drug resistance to targeted combined immunotherapy;Zhang;J. Clin. Hepatobiliary Dis.,2024
3. Nanomedicines: a theranostic approach for hepatocellular carcinoma;Usmani;Artif. Cells Nanomed. Biotechnol.,2018
4. Y. Deng, Y. DuanAdvances in the pathogenesis and drug therapy of primary liver cancer 30 Hebei Medical Science2024, , 345–348.
5. Advances in oral drug delivery systems: challenges and opportunities;Lou;Pharmaceutics,2023